Obesity, sleep apnoea and COVID-19: relationship, risk and therapeutic implications

W. Randerath (Solingen, Germany)

Source: Sleep and Breathing Conference 2021
Session: Sleep in the new era of COVID
Session type: Symposium
Number: 0

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Randerath (Solingen, Germany). Obesity, sleep apnoea and COVID-19: relationship, risk and therapeutic implications. Sleep and Breathing Conference 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
Source: Eur Respir J 2007; 29: 156-178
Year: 2007

Is obstructive sleep apnoea a risk factor for cardiovascular disease?
Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy
Year: 2005

Sleep apnoea and driving risk: the need for regulation
Source: Eur Respir Rev 2015; 24: 602-606
Year: 2015

Does the neutrophil-to-lymphocyte ratio have any importance between subjects with obstructive sleep apnea syndrome with obesity and without obesity?
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016

Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment
Source: Eur Respir J 2002; 20: 1511-1518
Year: 2002

Physical activity: the key to cardiometabolic risk reduction in obstructive sleep apnoea
Source: Eur Respir J, 52 (4) 1801775; 10.1183/13993003.01775-2018
Year: 2018

Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases?
Source: Sleep and Breathing Conference 2017
Year: 2017

Association between childhood obstructive sleep apnoea and risk of early osteoporosis.
Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill
Year: 2019

Sleep apnoea and risk of post-operative infection: beyond cardiovascular impact
Source: Eur Respir J , 49 (4) 1700292; DOI: 10.1183/13993003.00292-2017
Year: 2017

Late Breaking Abstract: Exposure to passive smoking as a risk factor for developing obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Passive smoking
Year: 2010

Obstructive sleep apnea, cardiometabolic risk, and levels of physical activity in Chilean adults
Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea
Year: 2017

Pharmacological management of sleep-disordered breathing
Source: Eur Respir Mon 2010; 50: 321-339
Year: 2010

Treatment effects of sleep apnoea: where are we now?
Source: Eur Respir Rev 2007; 16: 146-168
Year: 2007

Obstructive sleep apnoea: who should be treated?
Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives
Year: 2005

Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approaches
Source: Eur Respir J, 56 (2) 1902295; 10.1183/13993003.02295-2019
Year: 2020

Metabolic consequences in obstructive sleep apnoea
Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts
Year: 2006

Sleep-disordered breathing: a new risk factor of suspected fatty liver disease in overweight children and adolescents?
Source: Annual Congress 2007 - Sleep apnoea in childhood
Year: 2007

Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients
Source: Eur Respir J 2006; 28: Suppl. 50, 413s
Year: 2006

Menopause and cardiovascular risk factors in sleep apnea
Source: Eur Respir J 2006; 28: Suppl. 50, 200s
Year: 2006